Novo Nordisk, the maker of Ozempic and Wegovy ... CFO Karsten Knudsen said on an earnings call. Yes, but: Supply constraints are still affecting Ozempic and Wegovy — and the company said ...

A Novo executive said on an investor call Wednesday that the company is ... Novo posted fourth-quarter earnings of 6.34 kroner per share, or 88 cents, beating the FactSet consensus estimate ...

Novo Integrated Sciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings ...

LONDON/COPENHAGEN (Reuters) -Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, nearly doubled annual income and investment returns to a record 8 billion euros ($8.66 ...

Bullish option flow detected in Novo Nordisk (NVO ... volume in those strikes near 1,100 contracts. The Put/Call Ratio is 0.60. Earnings are expected on May 7th. Published first on TheFly ...